Voleon Capital Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
Voleon Capital Management's CORT Position: Q3 2026 in Review
Voleon Capital Management reduced its Corcept Therapeutics (CORT) stake by 74% in Q3 2026, selling an estimated $7.29M and leaving 24,186 shares worth $2.79M. The position accounts for 0.05% of the portfolio, ranked #300.
Voleon Capital Management first reported a position in CORT in Q3 2025 and has held it in 4 quarters since. The position peaked at $10.6M in Q1 2026. 500 funds tracked by Wall St. Rank hold CORT as of Q3 2026.
- Voleon Capital Management held 24,186 shares of Corcept Therapeutics worth $2.79M as of Q3 2026.
- Voleon Capital Management sold 67,740 Corcept Therapeutics shares in Q3 2026, an estimated $7.29M.
- Corcept Therapeutics made up 0.05% of Voleon Capital Management's portfolio in Q3 2026, its #300 holding.
- Voleon Capital Management first reported a position in Corcept Therapeutics in Q3 2025 and has held it in 4 quarters since.
- Voleon Capital Management's Corcept Therapeutics position peaked at $10.6M in Q1 2026.
- 500 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.
Based on Voleon Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.